Y
Yumi Fujimaki
Researcher at Chiba University
Publications - 27
Citations - 1027
Yumi Fujimaki is an academic researcher from Chiba University. The author has contributed to research in topics: Amyotrophic lateral sclerosis & Nerve conduction velocity. The author has an hindex of 15, co-authored 27 publications receiving 913 citations.
Papers
More filters
Journal ArticleDOI
Different neurological and physiological profiles in POEMS syndrome and chronic inflammatory demyelinating polyneuropathy
Saiko Nasu,Sonoko Misawa,Yukari Sekiguchi,Kazumoto Shibuya,Kazuaki Kanai,Yumi Fujimaki,Shigeki Ohmori,Satsuki Mitsuma,Shunsuke Koga,Satoshi Kuwabara +9 more
TL;DR: Before development of typical systemic manifestations, POEMS neuropathy can be distinguished from CIDP by the clinical profile and patterns of nerve conduction abnormalities.
Journal ArticleDOI
Antiganglioside antibodies are associated with axonal Guillain–Barré syndrome: A Japanese–Italian collaborative study
Yukari Sekiguchi,Antonino Uncini,Nobuhiro Yuki,Sonoko Misawa,Francesca Notturno,Saiko Nasu,Kazuaki Kanai,Yu Ichi Noto,Yumi Fujimaki,Kazumoto Shibuya,Shigeki Ohmori,Yasunori Sato,Satoshi Kuwabara +12 more
TL;DR: In this paper, clinical and electrophysiological features appear to be determined by antiganglioside antibodies, and the antibodies are associated with motor axonal GBS in both Japan and Italy.
Journal ArticleDOI
Motor axonal excitability properties are strong predictors for survival in amyotrophic lateral sclerosis
Kazuaki Kanai,Kazumoto Shibuya,Yasunori Sato,Sonoko Misawa,Saiko Nasu,Yukari Sekiguchi,Satsuki Mitsuma,Sagiri Isose,Yumi Fujimaki,Shigeki Ohmori,Shunsuke Koga,Satoshi Kuwabara +11 more
TL;DR: Axonal persistent sodium currents, estimated by strength–duration time constant and latent addition, are strong and independent predictors for shorter survival in patients with ALS.
Journal ArticleDOI
Elevated CSF TDP-43 levels in amyotrophic lateral sclerosis: Specificity, sensitivity, and a possible prognostic value
Yu Ichi Noto,Kazumoto Shibuya,Yasunori Sato,Kazuaki Kanai,Sonoko Misawa,Setsu Sawai,Masahiro Mori,Tomoyuki Uchiyama,Sagiri Isose,Saiko Nasu,Yukari Sekiguchi,Yumi Fujimaki,Takashi Kasai,Takahiko Tokuda,Masanori Nakagawa,Satoshi Kuwabara +15 more
TL;DR: The CSF TDP-43 is a potential biomarker that supports a diagnosis of ALS and among ALS patients, lower levels of CSFTDP- 43 may reflect the accumulation of T DP-43 in the cortical and spinal motor neurons and thereby shorter survival time, although this should be confirmed in larger prospective studies.
Journal ArticleDOI
Markedly upregulated serum interleukin-12 as a novel biomarker in POEMS syndrome
Kazuaki Kanai,Setsu Sawai,Kazuyuki Sogawa,Masahiro Mori,Sonoko Misawa,Kazumoto Shibuya,Sagiri Isose,Yumi Fujimaki,Yu-ichi Noto,Yukari Sekiguchi,Saiko Nasu,Chiaki Nakaseko,Shigetsugu Takano,Hideyuki Yoshitomi,Masaru Miyazaki,Fumio Nomura,Satoshi Kuwabara +16 more
TL;DR: The findings suggest that serum IL- 12 is a biomarker of the disease activity in POEMS syndrome, and the overproduction of IL-12, as well as VEGF, is likely to play an important role in the pathogenesis of the disorder.